Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel 17beta-HSD type 3 inhibitors and their use in cancer and prostate disorders

April 17, 2003

Ribozyme concludes Medizyme joint venture with Elan

April 16, 2003

Several series of B-Raf kinase inhibitors discovered at GSK

April 16, 2003

New Tie-2 and/or VEGFR2 kinase inhibitors prepared and tested by GSK scientists

April 16, 2003

OSI updates Tarceva program progress

April 15, 2003

Affitech and NatImmune collaborate in colon cancer

April 15, 2003

Antitumor duocarmycin analogues claimed by researchers at Scripps Research Institute

April 15, 2003

Probiodrug presents DPP-I inhibitors for use in cancer and other diseases

April 15, 2003

Optimization of farnesyltransferase inhibitors described at ACS by Pharmacopeia

April 15, 2003

Intracellular fate of NB-1011 characterized by NewBiotics scientists

April 15, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...